Abnormal liver function tests in patients with COVID‐19: relevance and potential pathogenesis
Lipopolysaccharide Reverses Hepatic Stellate Cell Activation... : Hepatology Lipopolysaccharide
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
Abstract Coronavirus Disease 2019 (COVID-19), emerged in early December 2019 in China
and became a pandemic situation worldwide by its rapid spread to more than 200 countries …
and became a pandemic situation worldwide by its rapid spread to more than 200 countries …
[HTML][HTML] Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
Background Tocilizumab, a monoclonal antibody directed against the interleukin-6 receptor,
has been proposed to mitigate the cytokine storm syndrome associated with severe COVID …
has been proposed to mitigate the cytokine storm syndrome associated with severe COVID …
Hydroxychloroquine for the prevention of Covid-19—searching for evidence
MS Cohen - New England Journal of Medicine, 2020 - Mass Medical Soc
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes
coronavirus disease 2019 (Covid-19), has generated a worldwide pandemic. The …
coronavirus disease 2019 (Covid-19), has generated a worldwide pandemic. The …
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
Background Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19.
Objective We set-up a multicenter Italian collaboration to investigate the relationship …
Objective We set-up a multicenter Italian collaboration to investigate the relationship …
[HTML][HTML] Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version)
YH Jin, QY Zhan, ZY Peng, XQ Ren, XT Yin… - Military Medical …, 2020 - Springer
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a
rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than …
rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than …
[HTML][HTML] Factores de riesgo asociados a mortalidad en pacientes adultos con neumonía por SARS-CoV-2 en un hospital público de Lima, Perú
MJM Rodríguez-Zúñiga, A Quintana-Aquehua… - Acta Médica …, 2020 - scielo.org.pe
Resumen RODRIGUEZ-ZUNIGA, Milton JM et al. Factores de riesgo asociados a mortalidad
en pacientes adultos con neumonía por SARS-CoV-2 en un hospital público de Lima, Perú …
en pacientes adultos con neumonía por SARS-CoV-2 en un hospital público de Lima, Perú …
[HTML][HTML] Preliminary experience with low molecular weight heparin strategy in COVID-19 patients
P Paolisso, L Bergamaschi, EC D'Angelo… - Frontiers in …, 2020 - frontiersin.org
Background Heparin administration in COVID-19 patients is recommended by expert
consensus, although evidence about dosage, duration and efficacy are limited. We aim to …
consensus, although evidence about dosage, duration and efficacy are limited. We aim to …
Treating COVID-19 with hydroxychloroquine (TEACH): a multicenter, double-blind randomized controlled trial in hospitalized patients
Background Effective therapies to combat coronavirus 2019 (COVID-19) are urgently
needed. Hydroxychloroquine (HCQ) has in vitro antiviral activity against severe acute …
needed. Hydroxychloroquine (HCQ) has in vitro antiviral activity against severe acute …
Compassionate use of tocilizumab for treatment of SARS-CoV-2 pneumonia
SC Jordan, P Zakowski, HP Tran… - Clinical Infectious …, 2020 - academic.oup.com
Background Preliminary data from severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) pneumonia patients indicate that a cytokine storm may increase morbidity and …
CoV-2) pneumonia patients indicate that a cytokine storm may increase morbidity and …